Recent Updates
Recently added Catalysts
HELP Positive Sentiment

Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston

Monday, August 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Helus Pharma is set to participate in the Canaccord Genuity 46th Annual Growth Conference in Boston. CEO Michael Halstead will engage in a fireside chat scheduled for August 12 at 12:00 p.m. EDT. This event presents an opportunity for the company to showcase its commitment to advancing mental health solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a notable conference enhances visibility.
  • CEO's involvement in a fireside chat indicates leadership engagement.
  • Opportunity to discuss innovative approaches in the pharmaceutical sector.

Full Press Release Details

CEO Michael Halstead to participate in a fireside chat on Wednesday, August 12 at 12:00 p.m. EDT NEW YORK and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to helping minds

Frequently Asked Questions

When is Helus Pharma's participation in the conference?

Helus Pharma will participate in the conference on August 12 at 12:00 p.m. EDT.

Who will represent Helus Pharma at the conference?

CEO Michael Halstead will represent Helus Pharma during the fireside chat.

What is the significance of the Canaccord Genuity conference?

The conference provides a platform for Helus Pharma to enhance its visibility and discuss its initiatives.

ShareAdd on Google
Tags: HELP Viatris Investor Conferences Healthcare Helus Pharma Canaccord Genuity CEO Michael Halstead pharmaceutical conference clinical-stage company
Last updated: Aug 10, 2026

Biotech snapshot

Lead asset
CYB003Phase 3
Major Depressive Disorder →